Katarzyna R. Przybylak
Unilever (United Kingdom)(GB)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Animal testing and alternatives, Effects and risks of endocrine disrupting chemicals, Pharmacogenetics and Drug Metabolism, Carcinogens and Genotoxicity Assessment
Most-Cited Works
- → Hepatotoxicity: A scheme for generating chemical categories for read-across, structural alerts and insights into mechanism(s) of action(2013)83 cited
- → In silicomodels for drug-induced liver injury – current status(2012)81 cited
- → Assessing toxicological data quality: basic principles, existing schemes and current limitations(2012)47 cited
- → Mechanism-Based QSAR Modeling of Skin Sensitization(2015)42 cited
- → In SilicoPrediction of Organ Level Toxicity: Linking Chemistry to Adverse Effects(2017)40 cited
- → Deposition of ZrO2 and HfO2 thin films by liquid injection MOCVD and ALD using ansa-metallocene zirconium and hafnium precursors(2008)39 cited
- → Assessment and Reproducibility of Quantitative Structure–Activity Relationship Models by the Nonexpert(2018)39 cited
- → Strategies for the optimisation of in vivo experiments in accordance with the 3Rs philosophy(2012)38 cited
- → Next generation risk assessment for skin allergy: Decision making using new approach methodologies(2022)36 cited
- → How Does the Quality of Phospholipidosis Data Influence the Predictivity of Structural Alerts?(2014)35 cited